Facial dysmorphology in children exposed in pregnancy to anticonvulsant medications correlates with deficits in IQ

Am J Med Genet A. 2024 Apr;194(4):e63511. doi: 10.1002/ajmg.a.63511. Epub 2023 Dec 21.

Abstract

Some children exposed at conception to the antiepileptic drugs (AEDs) phenytoin (PHT), phenobarbital (PB), and carbamazepine (CBZ) have changes in their midface and fingers. It has been suggested that the anticonvulsant-exposed child with these subtle changes in facial features (the "anticonvulsant face") has a greater likelihood of having deficits in IQ in comparison with children exposed to the same anticonvulsants who do not have these features. 115 AED-exposed children (40, PHT; 34, PB; and 41, CBZ) between 6.5 and 16 years of age and 111 unexposed children matched by sex, race, and year in school were evaluated. The evaluations were (WISC-III), physical examination with measurements of facial features and digits and photographs. The AED-exposed children had cephalometric radiographs, but not the unexposed. Each parent had a similar examination of face and hands plus tests of intelligence. These AED-exposed children showed an increased frequency of a short nose and anteverted nares, features of the "anticonvulsant face." Lateral skull radiographs showed a decrease in the angle between the anterior cranial base and nasal bone, which produces anteverted nares. Mean IQs were significantly lower on one or more IQ measures for the children with these facial features. Shortening of the distal phalanges and small fingernails correlated with the presence of a short nose in that child. The findings in 115 children exposed at conception to either phenytoin, phenobarbital, or carbamazepine, as monotherapy, confirmed the hypothesis that those with a short nose and anteverted nares had a lower IQ than exposed children without those features.

Keywords: anteverted nostrils; anticonvulsant face; carbamazepine; cephalometric radiographs; phenobarbital; phenytoin; short nose; small nails.

MeSH terms

  • Aged, 80 and over
  • Anticonvulsants / adverse effects
  • Carbamazepine / adverse effects
  • Child
  • Epilepsy* / drug therapy
  • Female
  • Humans
  • Musculoskeletal Abnormalities*
  • Phenobarbital / therapeutic use
  • Phenytoin / adverse effects
  • Pregnancy
  • Valproic Acid / therapeutic use

Substances

  • Anticonvulsants
  • Phenytoin
  • Phenobarbital
  • Carbamazepine
  • Valproic Acid

Grants and funding